It regulates blood sugar by stimulating insulin release in response to food, suppresses appetite by signaling satiety, slows gastric emptying to reduce glucose spikes, and reduces cravings making it a critical component of healthy metabolic balance
Beverage: A glass of wine (as part of your couple of nights a week)
4-6% placebo Diarrhea: 12-17% Vomiting: 5-10% Constipation: 6-11% Decreased appetite: 5-11% GI events are predominantly mild-moderate and occur mainly during dose escalation (first 4-8 weeks), with significant attenuation over time Serious adverse events of interest : Pancreatitis : Adjudicated pancreatitis events occurred at rates of approximately 0.1-0.2% across the SURPASS program, comparable to rates seen with GLP-1 agonists
Avoiding alcohol may be the safer choice if you have a history of pancreatitis, struggle with low blood sugar, are dealing with significant side effects, or your healthcare provider has advised you not to drink
You pay for the visit and medication you need and you can reorder on your own cadence